[DOI] [PMC free article] [PubMed] [Google Scholar] 6.De Nucci S., Castellana F., Zupo R., Lampignano L., Di Chito M., Rinaldi R., Giannuzzi V., Cozzolongo R., Piazzolla G., Giannelli G., et al
GLP-1 Receptor Agonist Market was valued at USD 27.27 billion in 2025 and is expected to reach USD 138.15 billion by 2035, growing at a CAGR of 17.61% from 2026-2035
Overall, our screen implicated 22 transcriptional regulators and 11 protein kinases in response to antifungal drugs, heavy metals, osmotic, oxidative and cell wall stress (Supplementary Table 1)
In people with IBD, the immune system malfunctions and causes inflammation in the GI tract
Successful weight management interventions can improve quality of life and mental health outcomes